NewAmsterdam Pharma Company
NAMS
#4234
Rank
โ‚ฌ2.61 B
Marketcap
22,35ย โ‚ฌ
Share price
-3.32%
Change (1 day)
8.66%
Change (1 year)

Earnings for NewAmsterdam Pharma Company (NAMS)

Earnings in 2026 (TTM): -โ‚ฌ0.19 Billion

According to NewAmsterdam Pharma Company's latest financial reports the company's current earnings are โ‚ฌ22.56 Million. In 2025 the company made an earning of -โ‚ฌ0.2 Billion, an increase over its 2024 earnings that were of -โ‚ฌ0.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for NewAmsterdam Pharma Company from 2023 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.19 Billion-5.6%
2025 -โ‚ฌ0.2 Billion-7.81%
2024 -โ‚ฌ0.22 Billion38.38%
2023 -โ‚ฌ0.16 Billion